1[1]Agnoletti L,Curello S,Bachetti T,et al.Serum from patients with severe heart failure downregulates eNOS and is proapoptic:role of tumor necrosis factor-alpha[J].Circulation,1999,100(19):1983-1991.
2[2]Packer M,Bristow MR,Cohn JN,et al.The effect of carvedilol on morbidity and mortality in patients with chronic heart failure.U.S.Carvedilol Heart Failure Study Group[J].N Engl J Med,1996,334(21):1349-1355.
3[3]Australianl/New Zealand Heart Failure Research Collaborative Group.Randomised placebo-controlled trial of carvedilol in patrents with congestive heart failure due to ischaemic heart disease[J].Lancet,1997,349 (9049):375-380.
4[4]Testa M,Yeh M,Lee P,et al.Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension[J].J Am Coll Cardiol,1996,28 (4):964-971.
5[5]Levine B,Kalman J,Mayer L,et al.Elevated circulating levels of tumor necrosis factor in severe chronic heart failure[J].N Engl J Med,1990,323(4):236-241.
6[6]Ferrari R,Bachetti T,Confortini R,et al.Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure[J].Circulation,1995,92(6):1479-1486.
7[7]White E.Life,death,and the pursuit of apoptosis[J].Genes Dev,1996,10(1):1-15.
9[9]Reed JC.Cytochrome c:can't live with it-can't live without it[J].Cell,1997,91(5):559-562.
10[10]Li P,Nijhawan D,Budihardjo I,et al.Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade[J].Cell,1997,91 (4):479-489.
